Skip to content
ChainView

Zimbabwe Turns Down ‘Unbalanced’ US Healthcare Assistance Package Over Data Apprehensions

Health funding image
The offered American funding was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a major US health deal worth $367m (272 million pounds) spanning five years over the United States' insistence on sensitive biological samples.

This move came to light after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "skewed".

A government spokesman has since clarified that the United States was requesting biological samples for scientific study and profit but was unwilling to share the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged continued talks to secure a deal agreeable to both sides so the country's critical HIV programme can proceed.

Wider Implications

This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of citizens' medical information.

Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and accountability.

Based on reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this partnership might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through American-funded programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.

"Put simply, our nation would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our citizens if a future disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining systems already set up through the international health agency.

Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This framework is intended to ensure that when a country contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be designed in a way that respects the independence and dignity of both nations."

Health Experts Response

Medical experts said it recognised the official position, but suggested that talks need to persist given that much of the nation's Aids initiatives relied on external financing.

"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.

This impasse emphasises the continuing tensions between accepting much-needed international aid and protecting local interests in an ever more data-driven world.

The writer

Donna Leonard

A blockchain researcher and crypto journalist with a background in fintech, specializing in decentralized finance trends.

ChainView

Type to search articles.